Anna Pan, PharmD

Commentary

GLP-1 Receptor Agonists vs Sulfonylureas for Reducing CV Events in Patients With Type 2 Diabetes

03/23/2023

Anna Pan, PharmD, PGY1 pharmacy resident, Kaiser Permanente, discusses a study in which she and coinvestigators analyzed the incidence of cardiovascular complications in patients with type 2 diabetes receiving either GLP-1 receptor agonists...

Anna Pan, PharmD, PGY1 pharmacy...

03/23/2023

Pharmacy Learning Network

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Anna Pan, PharmD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products